Second Tokushima Factory, Otsuka Pharmaceutical recalls
FDA enforcement reports naming Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. as the recalling firm.
- Recall reports
- 4
- Class I (serious)
- 0
- Most recent report
- May 1, 2024
- May 1, 2024Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka Am…Drug · Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.Cross Contamination with Other ProductsClass III
- May 1, 2024Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka Am…Drug · Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.Cross Contamination with Other ProductsClass III
- May 1, 2024Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka Ame…Drug · Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.Cross Contamination with Other ProductsClass III
- May 1, 2024Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-1…Drug · Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.Cross Contamination with Other ProductsClass III